Taking action early to manage emergence of acquired resistance to osimertinib or other third generation EGFR inhibitors

Detalles Bibliográficos
Autores principales: Ma, Guangzhi, Sun, Shi-Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2021
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443234/
https://www.ncbi.nlm.nih.gov/pubmed/34541036
http://dx.doi.org/10.18632/oncoscience.544

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443234/
https://www.ncbi.nlm.nih.gov/pubmed/34541036
http://dx.doi.org/10.18632/oncoscience.544

Ejemplares similares